Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients (Q91979008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

title

Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

Anna Falanga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Francesca Schieppati

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Laura Russo

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

publication date

1 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

Cancer Treatment and Research

26 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

volume

179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

11-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

Coagulation and cancer: biological and clinical aspects

26 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Venous thromboembolism and cancer: risks and outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Epidemiology of cancer-associated venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Epidemiology, risk and outcomes of venous thromboembolism in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

The coagulopathy of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Oncogenes and the coagulation system--forces that modulate dormant and aggressive states in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Risk stratification strategies for cancer-associated thrombosis: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

The mechanisms of cancer-associated thrombosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Development and validation of a predictive model for chemotherapy-associated thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Prediction of venous thromboembolism in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Platelets and cancer: a casual or causal relationship: revisited.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Prothrombotic genotypes and risk of venous thromboembolism in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Venous thrombosis: a multicausal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Thrombophilia and risk of venous thrombosis in patients with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients-results from the Vienna Cancer And Thrombosis Study (CATS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Venous thromboembolic disease and ABO blood type. A cooperative study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Epidemiology of cancer-related venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Anticancer treatment and thrombosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor expression correlates with histological grade in human pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Expression of tissue factor correlates with grade of malignancy in human glioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor expression and angiogenesis in human glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Mechanisms and risk factors of thrombosis in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Heparanase multiple effects in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Heparanase as mediator of angiogenesis: mode of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Heparanase procoagulant activity in cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Cell-derived microparticles: 'Miniature envoys with many faces'

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

New horizons in the analysis of circulating cell-derived microparticles

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Cancer and venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Venous thromboembolism in the hematologic malignancies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Microvesicle-associated tissue factor and Trousseau's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Hypercoagulability and tissue factor gene upregulation in hematologic malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tumor shedding and coagulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Microparticle-associated tissue factor activity: a link between cancer and thrombosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Microparticles in angiogenesis: therapeutic potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Platelet microparticles induce angiogenesis in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor in cancer progression and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Predictive value of tissue factor bearing microparticles in cancer associated thrombosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tumor cell procoagulant and urokinase expression in carcinoma of the ovary

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

High plasma levels of factor VIII and the risk of recurrent venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

High plasma levels of factor VIII and risk of recurrence of venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Coagulation factor levels in non-metastatic colorectal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Peaks in plasma plasminogen activator inhibitor-1 concentration may explain thrombotic events in cases of pancreatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Genetic and plasma markers of venous thromboembolism in patients with high grade glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Platelets and cancer-associated thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Mechanisms of thrombosis in cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Selectins promote tumor metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Mechanistic explanation for platelet contribution to cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Myeloproliferative neoplasms and thrombosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Extracellular DNA traps promote thrombosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

The pivotal role of thrombin in cancer biology and tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Flamethrowers: blood cells and cancer thrombosis risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Human blood monocytes are able to form extracellular traps.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Cancer-associated thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Cancer and thrombosis in women - molecular mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Hepatocyte nuclear factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Does hypercoagulability awaken dormant tumor cells in the host?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-030-20315-3_2

10.1007/978-3-030-20315-3_2

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31317478%20AND%20SRC:MED&resulttype=core&format=json